InvestorsHub Logo

daemon57

08/12/20 9:32 PM

#105231 RE: Saltz #105220

Wouldn't it be a conflict of interest or some issue if he's the CEO of the kit that's designed specifically for Leronlimab and he sits on the advisory board? Whether he's on the board or not, it's a symbiotic relationship nonetheless. BP knows the drug works and he has a kit specifically (with world wide distro being signed this week) designed for it. He promotes the drug, which he can sell a kit for. Every won wins. Not sure why people are making this more than it is, IMO.

GLTU/A.

ombowstring

08/12/20 10:40 PM

#105263 RE: Saltz #105220

I don't recall the name of the company that CytoDyn chose to analyze the lab data, but it is a well-respected, multi-national corporation that does a whole lot of this kind of work very capably. There's no need to pay top dollar to a one location operation headquartered in San Carlos, CA. Nader and crew made the right decision.

Maybe all the praise that has been heaped on Patterson has gone to his head. Haven't some people suggested BP should get a Nobel Prize for his discovery? He's no Bob Dylan, Nelson Mandela, or Madame Curie - or Albert Einstein.